Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.

about

Effects of soy isoflavones on the concentration of hyaluronic acid in the vagina of type 1 diabetic rats.Person-centred, web-based support in pregnancy and early motherhood for women with Type 1 diabetes mellitus: a randomized controlled trial.Premarriage Counseling in Type 1 Diabetes.

P2860

Q47652633-3A54E858-3E95-48DD-9874-4A0650B7E3A1 Q48243191-287CAD50-D6CD-40A3-91F0-9722D57E0C12 Q55452741-9840DCF8-A71D-4652-B705-4225F4F5F2E6

P2860

Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.

Item

http://www.wikidata.org/entity/Q38754271

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Using technology to advance ty ...... uctive years and in pregnancy.

@en

type

Item

label

Using technology to advance ty ...... uctive years and in pregnancy.

@en

prefLabel

Using technology to advance ty ...... uctive years and in pregnancy.

@en

P1476

Using technology to advance ty ...... ductive years and in pregnancy

@en

P2093

Dominique Giordano

http://www.w3.org/2001/XMLSchema#string

Mary K Voelmle

http://www.w3.org/2001/XMLSchema#string

Rachel Garcetti

http://www.w3.org/2001/XMLSchema#string

Satish K Garg

http://www.w3.org/2001/XMLSchema#string

P2860

Female reproduction and type 1 diabetes: from mechanisms to clinical findings

Fluctuations of Hyperglycemia and Insulin Sensitivity Are Linked to Menstrual Cycle Phases in Women With T1D.

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 St

Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?

Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).

STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.

Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus.

Internet use, needs and expectations of web-based information and communication in childbearing women with type 1 diabetes

Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.

P304

418-426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2016.1159910

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Sarit Polsky

P577

2016-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26924774

http://www.w3.org/2001/XMLSchema#string

P921

7bèla

type-1 diabetes

gestational diabetes

Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.

about

P2860

P2860

Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921